Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
131,900
Employees131,900
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
131,900
Employees131,900

JNJ Key Statistics

Market cap
386.35B
Market cap386.35B
Price-Earnings ratio
28.54
Price-Earnings ratio28.54
Dividend yield
3.01%
Dividend yield3.01%
Average volume
7.58M
Average volume7.58M
High today
$159.14
High today$159.14
Low today
$157.96
Low today$157.96
Open price
$158.15
Open price$158.15
Volume
6.18M
Volume6.18M
52 Week high
$175.97
52 Week high$175.97
52 Week low
$144.95
52 Week low$144.95

JNJ News

Benzinga 13h
Johnson & Johnson Has An Opportunity In Talc-Cancer Lawsuit, Can Challenge Scientific Evidence In Federal Ruling

Loading... Loading... Johnson & Johnson JNJ reportedly has an opportunity to challenge the scientific evidence linking talc to ovarian cancer, as U.S. District...

Johnson & Johnson Has An Opportunity In Talc-Cancer Lawsuit, Can Challenge Scientific Evidence In Federal Ruling
Benzinga 1d
Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst

Loading... Loading... Tuesday, Shockwave Medical Inc SWAV shares traded higher following a Wall Street Journal report suggesting Johnson & Johnson JNJ is repor...

Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst
Reuters 1d
UPDATE 2-J&J can contest evidence linking its talc to cancer, US judge rules

(Adds plaintiffs' lawyers statement in paragraph 7-8, background in paragraphs 10-11) By Dietrich Knauth NEW YORK, March 27 (Reuters) - Johnson & Johnson will...

UPDATE 2-J&J can contest evidence linking its talc to cancer, US judge rules

Analyst ratings

59%

of 22 ratings
Buy
40.9%
Hold
59.1%
Sell
0%

More JNJ News

TipRanks 1d
Judge gives J&J new chance to contest evidence on talc products, Reuters says

A federal judge determined that Johnson & Johnson will have another opportunity to contest the scientific evidence linking talc products ovarian cancer, Reuters...

TipRanks 2d
Piper says competitive process could materialize for ShockWave

Piper Sandler analyst Adam Maeder says the Wall Street Journal’s report of potential takeover interest reaffirms the view that ShockWave Medical (SWAV) is an “e...

TipRanks 2d
M&A News: JNJ Considers Shockwave Buyout

Pharmaceutical and medical technologies company Johnson & Johnson (NYSE:JNJ) is considering the acquisition of medical device maker Shockwave Medical (NASDAQ:SW...

Yahoo Finance 2d
Johnson & Johnson in talks to acquire Shockwave Medical: WSJ

Johnson & Johnson (JNJ) is in talks to acquire Shockwave Medical (SWAV), according to a report from The Wall Street Journal. Shockwave is a medical device maker...

Johnson & Johnson in talks to acquire Shockwave Medical: WSJ
Yahoo Finance 2d
Johnson & Johnson in talks to acquire Shockwave Medical: WSJ - Yahoo Finance

Johnson & Johnson (JNJ) is in talks to acquire Shockwave Medical (SWAV), according to a report from The Wall Street Journal. Shockwave is a medical device maker...

Johnson & Johnson in talks to acquire Shockwave Medical: WSJ - Yahoo Finance
Yahoo Finance 2d
J&J in talks to buy Shockwave Medical, WSJ reports - Yahoo Finance

FILE PHOTO: The logo of Johnson & Johnson is seen on the top of a Brussels' office of the company in Diegem (Reuters) -Johnson & Johnson is in talks to buy med...

J&J in talks to buy Shockwave Medical, WSJ reports - Yahoo Finance
The Wall Street Journal 2d
Shockwave Medical Stock Pops After Journal Reports Johnson & Johnson Interest

Shares of Shockwave Medical rose after the Journal reported that Johnson & Johnson is in talks to acquire the medical-device maker. Shockwave's stock was recent...

Shockwave Medical Stock Pops After Journal Reports Johnson & Johnson Interest
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.